Vanda Pharmaceuticals (VNDA) P/FCF US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| P/FCF | 13.7 | 13.3 | 19.5 | -17.1 | -4.71 | -3.34 | ||
| Changes by years, y/y, % | -4% | -3% | +46% | -188% | -73% | |||
Vanda Pharmaceuticals. P/FCF
Vanda Pharmaceuticals. P/FCF, changes, %
Vanda Pharmaceuticals (VNDA) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q1 | LTM ? | |||
| P/FCF | -4.22 | -3.54 | -4.72 | -5.35 | -3.23 | -3.34 | ||
| Changes by years, y/y, % | -93% | -76% | -73% | +14% | -31% | |||
| Changes by quarters, q/q, % | -10% | -16% | +33% | +13% | -40% | |||